Fundraising FoxOmnes Capital — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Antabio is a clinical-stage biopharmaceutical company developing novel antibacterial treatments for drug-resistant, Gram-negative bacterial infections identified as critical priorities by the WHO and CDC, with a focus on life-threatening hospital-acquired infections.
BiotechHealthtech
Marc Lemonnier(Chief Executive Officer)inRienk Pypstra(Chief Medical Officer)Gordon Waldron(Chief Financial Officer)inMagdalena Zalacain(Chief Scientific Officer)in
Co-investorsAMR Action FundBNP Paribas DéveloppementIRDI SORIDEC Gestion
Novaled develops materials for organic light-emitting diode (OLED) displays, including dopants, transport layers, and interlayer materials designed for high efficiency and durability.
Advanced ManufacturingDeep TechHardwareNew MaterialsSemiconductors
Co-investorseCAPITAL ENTREPRENEURIAL PARTNERS
Tilkee by Efalia is a sales tracking tool that generates a unique link to share commercial proposals and documents with prospects, then tracks engagement signals to identify decision-makers and reveal the best moment to close.
SaaSSales Tech
Timothée Saumet(Founder)in
Co-investorsAxeleo CapitalKREAXI
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.